Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2004-04-13
2008-08-05
Stockton, Laura L. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S355100
Reexamination Certificate
active
07407980
ABSTRACT:
Compounds of the Formula:where R1-R6are those defined herein and methods for producing the same. Also provided are pharmaceutical compositions comprising a Compound of Formula I and methods for their use as therapeutic agents.
REFERENCES:
patent: 5952362 (1999-09-01), Cournoyer et al.
patent: 6323231 (2001-11-01), Brioni et al.
patent: 6602897 (2003-08-01), Esser et al.
patent: 6756395 (2004-06-01), Dillon et al.
patent: 2002/0169193 (2002-11-01), Pouzet et al.
patent: 0 887 346 (1998-12-01), None
patent: 0 887 436 (1998-12-01), None
patent: 1336 228 (1973-11-01), None
Thompson et al., Current Medicinal Chemistry, Oct. 2002, 9(19), pp. 1751-1762.
Nardi, D., et al., Hypertensive Activity of 2-(2,3,4,6-tetramethylbenzyl) imidazoline and related compounds, (Research on Durene Derivatives),Farmaco., Ed. Sci. (1979) pp. 789-801, vol. 34(9).
Lis, R., et al., “Synthesis and Antiarrhythmic Activity of Novel 3-Alkyl-1-[w-[4-[(alkylsulfonyl)amino]phenyl]-w-hydroxyalkyl]-1H -imidazolium Salts and Related Compounds,”J. Med. Chem., (1987), pp. 2303-2309, vol. 30.
Mashkovski, M. D. Arzneimittel Handbuch für Aerzte, Teil I, Moskau, 1993, pp. 8.
Dillon Michael Patrick
Lin Clara Jeou Jen
O'Yang Counde
Zhang Xiaoming
Hall Robert C.
Roche Palo Alto LLC
Stockton Laura L.
LandOfFree
Imidazolinylmethyl aralkylsulfonamides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Imidazolinylmethyl aralkylsulfonamides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imidazolinylmethyl aralkylsulfonamides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3998957